The Omar Boraie Chair In Genomic Science Creates Hope For Cancer Patients
As Rutgers Cancer Institute continues its “18 Chair Challenge” with the addition of the Omar Boraie Chair in Genomic Science. Shridar Ganesan, MD, PhD, is named the sear of the chair, being both an associate professor of medicine and pharmacology and the principal investigator of precision medicine clinical trials at Rutgers Cancer Institute.
During the most recent State of the Union Address, President Obama noted that the future of cancer research and treatment is in genomic science and launched a national Precision Medicine Initiative to help focus institutions and scientists alike in this new and exciting field of medicine. The goal is ideally to find a cure for cancer and other diseases such as leukemia.
While many cancer centers use next-generation gene sequencing for research of tumors, Rutgers Cancer Institute was one of the first in the country as well-being currently the only in the state of New Jersey to utilize genomic sequencing as a tactic for personalized patient care. Gene sequencing allows medical-scientists to treat cancers on a one-by-one basis and divide cancers into specific categories. This ability to classify cancers at the genetic level has been valuable for finding therapies for patients with rare cancers and those who have little or no results with current treatment options. Laboratory discoveries at the clinic lead to new and improved clinical practice, and innovative diagnosis and treatment for patients.
Omar Boraie is no newcomer to supporting medical sciences. As part of Omar Boraie’s initiative to recreate the New Jersey city of New Brunswick into the “Healthcare City”, he built housing, affordable living housing and many commercial offices to entice doctors and medical professionals to come back. His supporting a chair at the Rutgers University Cancer Center is just his most recent approach to helping the medical community.
While each chair is funded by $1.5 million donations, an anonymous donor has offered to provide an additional $1.5 million for each chair, meaning a $3 million endowment for the Omar Boraie Chair in Genomic Science and others to be established. These funds will provide means to further expand the department and continue making groundbreaking discoveries and offer cutting-edge treatment options to cancer patients, and be an integral part in changing the face of cancer medicine as we know it.